Ad-hoc | 23 February 2011 06:54
Fresenius Medical Care AG & Co. KGaA / Key word(s): Final Results/Forecast
23.02.2011 06:54
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Fresenius Medical Care Reports Full Year 2010 Results
Net revenue of Fresenius Medical Care AG & Co. KGaA for the full year 2010
was $12,053 million, up 7% from the full year 2009.
Operating income (EBIT) increased by 10% to $1,924 million.
For the full year 2010, net income attributable to Fresenius Medical Care
AG & Co. KGaA was $979 million, up 10% from 2009.
For the 14th consecutive year, shareholders can expect to receive an
increased annual dividend. At the Annual General Meeting to be held on May
12, 2010, shareholders will be asked to approve a dividend per ordinary
share of EUR0.65, an increase of 7% (2009: EUR0.61).
For the full year 2011, Fresenius Medical Care expects revenue to grow to
between US$ 12.8 billion and US$ 13.0 billion, corresponding to a growth
rate of 6% to 8%. Net income attributable to Fresenius Medical Care AG &
Co. KGaA is expected to be between US$1.035 billion and US$1.055 billion,
with operating margins forecast to increase by approximately 20 basis
points. The net income guidance does not consider a reduction of the
'transition adjuster' for US clinics in 2011.
For 2011, Fresenius Medical Care expects to spend around 5 % of revenue on
capital expenditure and approximately $ 1.2 billion on acquisitions.
Fresenius SE (WKN 578560) holds approximately 35% of Fresenius Medical Care
AG & Co. KGaA's capital.
Fresenius Medical Care AG & Co. KGaA,
Represented by Fresenius Medical Care Management AG,
Board of Management,
Bad Homburg v.d.H., February 23, 2011
23.02.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Deutschland
Phone: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: ir@fmc-ag.com
Internet: www.fmc-ag.de
ISIN: DE0005785802, DE0005785836,
WKN: 578580, 578583
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
Terminbörse EUREX; NYSE
End of Announcement DGAP News-Service
---------------------------------------------------------------------------